Skip to main content
. Author manuscript; available in PMC: 2016 Jan 31.
Published in final edited form as: Liver Transpl. 2015 Feb;21(2):187–194. doi: 10.1002/lt.24042

Table 2.

Tumor characteristics of HCC liver transplant recipients.

Total
Population
(n=5002)
Donor Age
<60 (n=4162)
Donor Age
≥60 (n=840)
Local Share
(n=3957)
Non-local
(n=1045)
Tumor
Characteristics
n (%) n (%) n (%) p value n (%) n (%) p value
Tumor number and size
  >1 tumor all <2cm 630 (12.6) 504 (12.1) 126 (15.0) 0.02 493 (12.5) 137 (13.1) 0.57
  1 tumor ≥2cm or multiple tumors with only 1 ≥2cm 4077 (81.5) 3424 (82.3) 653 (77.7) 0.002 3237 (81.8) 840 (80.4) 0.29
  2–3 tumors ≥2cm 295 (5.9) 234 (5.6) 61 (7.3) 0.06 227 (5.7) 68 (6.5) 0.35
Milan criteria at exception 4946 (98.9) 4117 (98.9) 829 (98.7) 0.57 3916 (99.0) 1030 (98.6) 0.28
Ablative therapy at exception 2167 (43.3) 1827 (43.9) 340 (40.5) 0.07 1727 (43.6) 440 (42.1) 0.37
AFP >500 ng/mL at exception 293 (5.9) 248 (6.0) 45 (5.4) 0.50 240 (6.1) 53 (5.1) 0.22
HCC recurrence 324 (6.5) 244 (5.9) 80 (9.5) <0.001 236 (6.0) 88 (8.4) 0.004
Non-HCC death 866 (17.3) 682 (16.4) 184 (21.9) <0.001 667 (16.9) 199 (19.0) 0.10
Median (IQR) Median (IQR) Median (IQR) p value Median (IQR) Median (IQR) p value
Total tumor volume at exception (cm3) 9.2 (5.6–17.2) 9.2 (5.6–17.2) 9.7 (4.8–17.2) 0.68 9.2 (5.6–17.2) 9.4 (5.6–17.2) 0.71
Tumor size of main nodule (cm) 2.4 (2.0–3.1) 2.4 (2.0–3.1) 2.3 (1.8–3.0) 0.02 2.4 (2.0–3.1) 2.4 (2.0–3.1) 0.99
HHS Vulnerability Disclosure